Richland provides evidence-based medical weight management programs incorporating the latest weight loss medications including Semaglutide (Ozempic, Wegovy), Tirzepatide (Mounjaro, Zepbound), and other GLP-1 receptor agonists
Genuine patients, who would benefit tremendously from these drugsdiabetics or obese individuals with comorbiditiesmay shun these drugs, for fear of side effects
Research from Washington University tracking 333,687 U.S
With the growing popularity of peptide products, many online sellers claim to provide similar compounds
While higher intakes are sometimes used in practice, evidence suggests that amounts above this level do not consistently provide additional benefit for most people
Normally distributed baseline characteristics are presented as mean and SD